It has been reported that BIRC5 is commonly overexpressed in gastrointestinal NETs and other cancer types, and overexpression has been related to low radiosensitivity and worse prognosis29–31. This evidence concerns the gene BIRC5 and digestive system neuroendocrine tumor, grade 1/2.